Table 1.
Demographic, clinical and laboratory data.
| Variables | Left ventricular remodeling | P value | |
|---|---|---|---|
| Yes (n=38) | No (n=28) | ||
| Age (yrs) | 57±11 | 61±14 | 0.238 |
| Male (%) | 71 | 82 | 0.454 |
| HP (%) | 60 | 53 | 0.754 |
| DM (%) | 29 | 25 | 0.939 |
| Dyslipidemia (%) | 82 | 89 | 0.498 |
| Smoking (%) | 45 | 29 | 0.280 |
| BMI (kg/m2) | 27±4 | 26±4 | 0.416 |
| CPK (U/L) | 6851 (3963–8734) | 1525 (841–4364) | <0.001 |
| CPK-MB (U/L) | 512 (318–664) | 183 (107–454) | 0.002 |
| HR (beats/min) | 85±14 | 72±16 | 0.001 |
| Heart failure (%) | 64 | 27 | 0.007 |
| SB (%) | 18 | 0 | 0.018 |
| Reperfusion (%) | 94 | 75 | 0.030 |
| TIMI ≥2 (%) | 88 | 96 | 0.384 |
HP – hypertension; DM – diabetes mellitus; BMI – body mass index; SB – shortness of breath; CPK – creatine phosphokinase; CPK-MB – creatine phosphokinase – MB; TIMI – Thrombolysis In Myocardial Infarction grade. Data are expressed as the mean ±SD or the median (including the lower and upper quartiles).